Galderma receives FDA approval for AKLIEF
The Food and Drug Administration (FDA) has approved AKLIEF (trifarotene) Cream 0.005% for the topical treatment of acne.
The Food and Drug Administration (FDA) has approved AKLIEF (trifarotene) Cream 0.005% for the topical treatment of acne.
Global pharmaceutical company Allergan has received US Food and Drug Administration (FDA) approval for the use of Juvéderm VOLUMA XC with a TSK STERiGLIDE cannula for cheek augmentation to correct age-related volume definition in the mid-face in adults over 21.
On March 19 the Food and Drug Administration (FDA) issued letters of warning to two US breast implant manufacturers, Mentor Worldwide LLC and Sientra Inc.
The Food and Drug Administration (FDA) has approved Jeuveau, a botulinum toxin type A, for the temporary improvement in the appearance of moderate to severe glabellar lines.